XNAS: LRMR
Larimar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-...
Read More
4.59
-0.18
(-3.77%)
3.8M
XNAS Volume
XNAS 13 Mar, 2026 4:08 PM (EDT)
Board Meeting
The next board meeting for Larimar Therapeutics Inc is on 24 Mar 2026 for the purpose of Larimar Therapeutics Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Larimar Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..